| Bioactivity | MK-1421 is a potent and selective sstr3 antagonist. MK-1421 regulates insulin secretion by binding to the sstr3. MK-1421 can be used in the research of type 2 diabetes[1]. |
| CAS | 1235995-16-0 |
| Formula | C27H24FN9O2 |
| Molar Mass | 525.54 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Shah S K, et al. Discovery of MK-1421, a potent, selective sstr3 antagonist, as a development candidate for type 2 diabetes[J]. ACS Medicinal Chemistry Letters, 2015, 6(5): 513-517. |
MK-1421
CAS: 1235995-16-0 F: C27H24FN9O2 W: 525.54
MK-1421 is a potent and selective sstr3 antagonist. MK-1421 regulates insulin secretion by binding to the sstr3. MK-1421
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.